Editas Medicine Inc
EDIT
Market Cap$456.4M
Close$
$9.73
78.2% upside
Current Fair Value
78.2% upsideUndervalued by 78.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $456.40 Million |
|---|---|
| Enterprise Value | $133.29 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.02 |
| Beta | 1.31 |
| Outstanding Shares | 82,234,710 |
| Avg 30 Day Volume | 1,661,053 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.98 |
|---|---|
| PEG | 4.32 |
| Price to Sales | - |
| Price to Book Ratio | 1.37 |
| Enterprise Value to Revenue | 1.71 |
| Enterprise Value to EBIT | -0.79 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Editas Medicine Inc
CEO: Cynthia Collins